• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $PETS

    PetMed Express Inc.

    Subscribe to $PETS
    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    PetMed Express, Inc., together with its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, and other health products for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, strollers, and other pet supplies. It sells its products through its Internet website and mobile app; telephone contact center; and direct mail/print through catalogs, brochures, and postcards. PetMed Express, Inc. was incorporated in 1996 and is headquartered in Delray Beach, Florida.

    IPO Year:

    Exchange: NASDAQ

    Website: 1800petmeds.com

    Peers

    $CHWY

    Recent Analyst Ratings for PetMed Express Inc.

    DatePrice TargetRatingAnalyst
    5/25/2023$20.00Buy
    Lake Street
    1/25/2022$25.00 → $21.00Underweight
    Morgan Stanley
    1/20/2022$32.00Neutral → Buy
    Sidoti
    11/18/2021$25.00Underweight
    Morgan Stanley
    10/1/2021$28.00Hold
    Jefferies
    8/5/2021$22.00Underperform
    Credit Suisse
    See more ratings

    PetMed Express Inc. Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Large owner Nina Capital Holdings Inc. bought $408,500 worth of shares (100,000 units at $4.08), increasing direct ownership by 4% to 2,500,000 units (SEC Form 4)

      4 - PETMED EXPRESS INC (0001040130) (Issuer)

      3/19/25 4:19:50 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Large owner Nina Capital Holdings Inc. bought $411,000 worth of shares (100,000 units at $4.11), increasing direct ownership by 4% to 2,400,000 units (SEC Form 4)

      4 - PETMED EXPRESS INC (0001040130) (Issuer)

      3/11/25 4:15:04 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Large owner Nina Capital Holdings Inc. bought $216,250 worth of shares (50,000 units at $4.33), increasing direct ownership by 2% to 2,300,000 units (SEC Form 4)

      4 - PETMED EXPRESS INC (0001040130) (Issuer)

      3/4/25 4:16:01 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Large owner Nina Capital Holdings Inc. bought $120,500 worth of shares (25,000 units at $4.82), increasing direct ownership by 1% to 2,250,000 units (SEC Form 4)

      4 - PETMED EXPRESS INC (0001040130) (Issuer)

      2/4/25 6:01:23 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Large owner Nina Capital Holdings Inc. bought $239,550 worth of shares (50,000 units at $4.79), increasing direct ownership by 2% to 2,225,000 units (SEC Form 4)

      4 - PETMED EXPRESS INC (0001040130) (Issuer)

      1/28/25 4:15:24 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Large owner Nina Capital Holdings Inc. bought $124,375 worth of shares (25,000 units at $4.97), increasing direct ownership by 1% to 2,175,000 units (SEC Form 4)

      4 - PETMED EXPRESS INC (0001040130) (Issuer)

      1/10/25 4:05:32 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Large owner Nina Capital Holdings Inc. bought $180,960 worth of shares (32,000 units at $5.66), increasing direct ownership by 2% to 2,150,000 units (SEC Form 4)

      4 - PETMED EXPRESS INC (0001040130) (Issuer)

      12/18/24 4:15:28 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Large owner Nina Capital Holdings Inc. bought $222,000 worth of shares (40,000 units at $5.55), increasing direct ownership by 2% to 2,118,000 units (SEC Form 4)

      4 - PETMED EXPRESS INC (0001040130) (Issuer)

      12/10/24 4:15:30 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Director Campbell Leslie C.G. bought $324,636 worth of shares (60,000 units at $5.41), increasing direct ownership by 55% to 85,000 units (SEC Form 4)

      4 - PETMED EXPRESS INC (0001040130) (Issuer)

      12/6/24 9:06:40 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Large owner Nina Capital Holdings Inc. bought $41,750 worth of shares (12,500 units at $3.34), increasing direct ownership by 0.61% to 2,078,000 units (SEC Form 4)

      4 - PETMED EXPRESS INC (0001040130) (Issuer)

      10/18/24 8:18:58 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    PetMed Express Inc. Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by PetMed Express Inc.

      SC 13G - PETMED EXPRESS INC (0001040130) (Subject)

      11/14/24 4:02:14 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • SEC Form SC 13G filed by PetMed Express Inc.

      SC 13G - PETMED EXPRESS INC (0001040130) (Subject)

      10/10/24 6:26:43 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • SEC Form SC 13G/A filed by PetMed Express Inc. (Amendment)

      SC 13G/A - PETMED EXPRESS INC (0001040130) (Subject)

      2/13/24 5:12:03 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • SEC Form SC 13G filed by PetMed Express Inc.

      SC 13G - PETMED EXPRESS INC (0001040130) (Subject)

      2/13/24 9:25:26 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • SEC Form SC 13G/A filed by PetMed Express Inc. (Amendment)

      SC 13G/A - PETMED EXPRESS INC (0001040130) (Subject)

      1/26/23 10:11:32 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • SEC Form SC 13G/A filed by PetMed Express Inc. (Amendment)

      SC 13G/A - PETMED EXPRESS INC (0001040130) (Subject)

      2/10/22 5:25:14 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • SEC Form SC 13G filed by PetMed Express Inc.

      SC 13G - PETMED EXPRESS INC (0001040130) (Subject)

      2/10/22 4:01:09 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • SEC Form SC 13G/A filed by PetMed Express Inc. (Amendment)

      SC 13G/A - PETMED EXPRESS INC (0001040130) (Subject)

      2/10/22 8:32:45 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • SEC Form SC 13G/A filed

      SC 13G/A - PETMED EXPRESS INC (0001040130) (Subject)

      2/11/21 11:52:37 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • SEC Form SC 13G/A filed

      SC 13G/A - PETMED EXPRESS INC (0001040130) (Subject)

      2/10/21 11:40:10 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    PetMed Express Inc. Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Lake Street initiated coverage on PetMed Express with a new price target

      Lake Street initiated coverage of PetMed Express with a rating of Buy and set a new price target of $20.00

      5/25/23 9:17:49 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Morgan Stanley reiterated coverage on PetMed Express with a new price target

      Morgan Stanley reiterated coverage of PetMed Express with a rating of Underweight and set a new price target of $21.00 from $25.00 previously

      1/25/22 10:17:17 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • PetMed Express upgraded by Sidoti with a new price target

      Sidoti upgraded PetMed Express from Neutral to Buy and set a new price target of $32.00

      1/20/22 9:13:56 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Morgan Stanley initiated coverage on PetMed Express with a new price target

      Morgan Stanley initiated coverage of PetMed Express with a rating of Underweight and set a new price target of $25.00

      11/18/21 8:47:20 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Jefferies initiated coverage on PetMed Express with a new price target

      Jefferies initiated coverage of PetMed Express with a rating of Hold and set a new price target of $28.00

      10/1/21 5:07:22 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Credit Suisse resumed coverage on PetMed Express with a new price target

      Credit Suisse resumed coverage of PetMed Express with a rating of Underperform and set a new price target of $22.00

      8/5/21 6:25:35 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • PetMed Express downgraded by Sidoti with a new price target

      Sidoti downgraded PetMed Express from Buy to Neutral and set a new price target of $39.00

      6/3/21 8:42:02 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • PetMed Express upgraded by Sidoti

      Sidoti upgraded PetMed Express from Neutral to Buy

      3/11/21 8:07:24 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • PetMed Express upgraded by Sidoti

      Sidoti upgraded PetMed Express from Neutral to Buy

      3/5/21 9:52:24 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • PetMed Express downgraded by Sidoti

      Sidoti downgraded PetMed Express from Buy to Neutral

      1/27/21 1:54:01 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    PetMed Express Inc. Financials

    Live finance-specific insights

    See more
    • PetMeds® Announces Third Quarter Fiscal 2025 Financial Results

      DELRAY BEACH, Fla., Feb. 10, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ:PETS) today announced its financial results for its third quarter ended December 31, 2024. Third Quarter Fiscal 2025 Financial Highlights Net sales of $53.0 million. Gross margin rate of 28.1%, an increase of 80 basis points compared to the prior year period. Adjusted EBITDA of $2.0 million compared to Adjusted EBITDA of $0.9 million in the prior year period. Continued progress on key initiatives supporting the transformation of the business. "In just nine months, we have made significant strides in our transformation journey, and I am pleased to report that

      2/10/25 4:05:00 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • PetMed Express, Inc. Sets Fiscal Third Quarter 2025 Earnings Call

      DELRAY BEACH, Fla., Jan. 30, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) will hold a conference call on Monday, February 10, 2025 at 4:30pm Eastern Time to discuss its financial results for the fiscal third quarter ended December 31, 2024. Financial results will be issued in a press release prior to the call. PETS management will host the conference call, followed by a question-and-answer period. Please call the conference telephone number 5-10 minutes prior to the start time. Date: Monday, February 10, 2025Time: 4:30pm Eastern Time (1:30pm Pacific Time)U.S. dial-in number: 877-407-0789International number: 201-689-8562Webcast

      1/30/25 4:05:00 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • PetMeds® Adopts Limited Duration Shareholder Rights Plan

      DELRAY BEACH, Fla., Dec. 03, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ:PETS) ("PetMeds" or the "Company"), today announced that its Board of Directors (the "Board") has adopted a limited duration shareholder rights plan to protect the best interests of all PetMeds shareholders (the "Rights Plan"). The Board adopted the Rights Plan to protect the investment of shareholders during a period in which it believes shares of the Company do not reflect the inherent value of the business or its long-term growth potential, and during which there have been recent significant accumulations of Company common stock by certain shareholders.

      12/3/24 8:30:00 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • PetMeds® Announces Second Quarter Fiscal 2025 Financial Results

      DELRAY BEACH, Fla., Nov. 06, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ:PETS) today announced its financial results for its second quarter ended September 30, 2024. Second Quarter Fiscal 2025 Financial Highlights Net sales of $59.6 million.Gross margin of 29.1%, an increase of 0.8% compared to the prior year period.Net income of $2.3 million, or $0.11 per diluted share, compared to net income of $0.7 million, or $0.03 per diluted share, in the prior year period.  Adjusted EBITDA of $2.1 million improved sequentially from an Adjusted EBITDA loss of $(1.5) million in the first quarter of fiscal 2025 and compared to Adjusted EBITDA of $

      11/6/24 4:05:00 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • PetMed Express, Inc. Sets Fiscal Second Quarter 2025 Earnings Call

      DELRAY BEACH, Fla., Oct. 24, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) will hold a conference call on Wednesday, November 6, 2024 at 4:30pm Eastern Time to discuss its financial results for the fiscal second quarter ended September 30, 2024. Financial results will be issued in a press release prior to the call. PETS management will host the conference call, followed by a question-and-answer period. Please call the conference telephone number 5-10 minutes prior to the start time. Date: Wednesday, November 6, 2024Time: 4:30pm Eastern Time (1:30pm Pacific Time)U.S. dial-in number: 877-407-0789International number: 201-689-8

      10/24/24 8:00:00 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • PetMeds® Announces Fiscal 2025 First Quarter Financial Results

      DELRAY BEACH, Fla., Aug. 06, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ:PETS) today announced its financial results for its first quarter ended June 30, 2024. Quarterly Highlights for Q1, Fiscal 2025 Net sales were $68 million, (13)% lower than the prior year comparable quarter.Net income was $3.8 million, or $0.18 diluted earnings per share. This compares to net loss of $(1.1) million, or $(0.06) diluted earnings per share, for the prior year comparable quarter.Increase in net income is primarily attributed to a $8.7 million reversal of accumulated stock compensation expense associated with departure of the former CEO, partially off

      8/6/24 4:05:00 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • PetMed Express, Inc. Sets Fiscal First Quarter 2025 Earnings Call

      DELRAY BEACH, Fla., July 23, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) will hold a conference call on Tuesday, August 6, 2024 at 4:30pm Eastern time to discuss its financial results for the fiscal first quarter ended June 30, 2024. Financial results will be issued in a press release prior to the call. PETS management will host the conference call, followed by a question-and-answer period. Please call the conference telephone number 5-10 minutes prior to the start time. Date: Tuesday, August 6, 2024Time: 4:30pm Eastern time (1:30pm Pacific time)U.S. dial-in number: 844-826-3035International number: 412-317-5195Webcast: 1Q Ear

      7/23/24 8:00:00 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • PetMeds® Announces Its Fourth Quarter and Fiscal Year End Financial Results

      DELRAY BEACH, Fla., June 11, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ:PETS) today announced its financial results for its fourth quarter and fiscal year ended March 31, 2024.  Quarterly Highlights Net sales for the quarter ended March 31, 2024, were $66.5 million, compared to $62.4 million for the fourth quarter in the prior year, an increase of 6.6%, driven by the acquisition of PetCareRx partially offset by a decline in PetMeds legacy sales.Net loss for the quarter ended March 31, 2024 was $(5.0) million, or $(0.25) diluted earnings per share. This compares to net loss of $(0.2) million, or $(0.01) diluted earnings per share, for

      6/11/24 4:05:00 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • PetMed Express, Inc. Sets Fourth Quarter and Full Fiscal Year 2024 Earnings Call

      DELRAY BEACH, Fla., May 22, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) ("PetMeds"), will hold a conference call on Tuesday, June 11, 2024 at 4:30pm Eastern time to discuss its financial results for the fourth quarter and full fiscal year ended March 31, 2024. Financial results will be issued in a press release prior to the call. PETS management will host the conference call, followed by a question-and-answer period. Please call the conference telephone number 5-10 minutes prior to the start time. Date: Tuesday, June 11, 2024Time: 4:30pm Eastern time (1:30pm Pacific time)U.S. dial-in number: 877-407-0789International number: 2

      5/22/24 4:05:00 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • PetMeds® Announces Fiscal 2024 Third Quarter Financial Results and Completion of Financial Restatement

      Fiscal 2024 3Q Revenue of $65.3 million, an 11% increase compared to last year including PetCareRx results.AutoShip & Save and PetPlus Membership, 52% of total revenue, up from 42% at the same time last year.Strong balance sheet with $49.4 million of cashThe Company is now current in all of its SEC filings DELRAY BEACH, Fla., April 15, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ:PETS)("PetMeds" or "Company"), Your Trusted Pet Health ExpertTM, today announced its financial results for its third quarter of fiscal year 2024, restated financial statements for the years ended March 31, 2023, 2022 and 2021, and interim financial statements for previously reported quarterly periods in

      4/15/24 8:16:00 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    PetMed Express Inc. Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • CEO & President Campos Sandra Yvette sold $200,090 worth of shares (60,463 units at $3.31), decreasing direct ownership by 9% to 578,524 units (SEC Form 4)

      4 - PETMED EXPRESS INC (0001040130) (Issuer)

      5/2/25 8:57:58 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Director Batushansky Peter was granted 2,527 shares (SEC Form 4)

      4 - PETMED EXPRESS INC (0001040130) (Issuer)

      4/11/25 4:17:25 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • SEC Form 3 filed by new insider Batushansky Peter

      3 - PETMED EXPRESS INC (0001040130) (Issuer)

      4/11/25 4:09:36 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Large owner Nina Capital Holdings Inc. bought $408,500 worth of shares (100,000 units at $4.08), increasing direct ownership by 4% to 2,500,000 units (SEC Form 4)

      4 - PETMED EXPRESS INC (0001040130) (Issuer)

      3/19/25 4:19:50 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Large owner Nina Capital Holdings Inc. bought $411,000 worth of shares (100,000 units at $4.11), increasing direct ownership by 4% to 2,400,000 units (SEC Form 4)

      4 - PETMED EXPRESS INC (0001040130) (Issuer)

      3/11/25 4:15:04 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Large owner Nina Capital Holdings Inc. bought $216,250 worth of shares (50,000 units at $4.33), increasing direct ownership by 2% to 2,300,000 units (SEC Form 4)

      4 - PETMED EXPRESS INC (0001040130) (Issuer)

      3/4/25 4:16:01 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Large owner Nina Capital Holdings Inc. bought $120,500 worth of shares (25,000 units at $4.82), increasing direct ownership by 1% to 2,250,000 units (SEC Form 4)

      4 - PETMED EXPRESS INC (0001040130) (Issuer)

      2/4/25 6:01:23 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Large owner Nina Capital Holdings Inc. bought $239,550 worth of shares (50,000 units at $4.79), increasing direct ownership by 2% to 2,225,000 units (SEC Form 4)

      4 - PETMED EXPRESS INC (0001040130) (Issuer)

      1/28/25 4:15:24 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • CEO & President Campos Sandra Yvette was granted 146,772 shares, increasing direct ownership by 30% to 638,987 units (SEC Form 4)

      4 - PETMED EXPRESS INC (0001040130) (Issuer)

      1/17/25 7:00:56 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Vice President of People Smith Jacqueline Paula was granted 8,000 shares, increasing direct ownership by 40% to 28,099 units (SEC Form 4)

      4 - PETMED EXPRESS INC (0001040130) (Issuer)

      1/17/25 4:09:30 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    PetMed Express Inc. Leadership Updates

    Live Leadership Updates

    See more
    • PetMeds® to Ring Nasdaq Opening Bell in Celebration of National Pet Day on April 11th

      DELRAY BEACH, Fla., April 11, 2025 (GLOBE NEWSWIRE) -- In celebration of National Pet Day, PetMed Express, Inc. (NASDAQ:PETS)—the original consumer pet healthcare company serving dogs, cats, and horses for nearly 30 years—will ring the Nasdaq Opening Bell this Friday, April 11, 2025. This momentous occasion honors the powerful bond between people and their pets and will feature adoptable rescue dogs from Bidawee, one of the nation's oldest no-kill animal welfare organizations. It's a tribute to the joy and unconditional love pets bring into our lives–and a reminder of how many still await families of their own. "Our pets are more than just animals; they are family," said Sandra Campo

      4/11/25 9:00:00 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • PetMed Express, Inc. Announces Appointment of Peter Batushansky to Board of Directors

      Former pet industry executive with more than 20 years of experience across retail, pet, healthcare, and private equity Third independent director to join the Board since 2024 Longtime board member and former Chairman Dr. Gian Fulgoni will retire DELRAY BEACH, Fla., April 09, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., parent company of PetMeds and PetCareRx, (NASDAQ:PETS) (the "Company") today announced the appointment of Peter Batushansky to the Company's Board of Directors ("the Board"), effective April 09, 2025. Mr. Batushansky is currently a Partner at L2 Capital Partners and brings to the Board more than 20 years of experience across retail, pet, healthcare and private equity, i

      4/9/25 8:00:00 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • PetMed Express, Inc. Announces Appointment of Robyn D'Elia as Chief Financial Officer

      DELRAY BEACH, Fla., Sept. 12, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) (the "Company") today announced the appointment of retail and ecommerce veteran Robyn D'Elia as Chief Financial Officer ("CFO") effective September 16, 2024. D'Elia brings over 25 years of experience in financial leadership and strategic planning across multiple industries, including 24 years at Bed Bath & Beyond where she served in senior leadership roles across finance for two decades, and served as CFO from 2018 to 2020. Most recently D'Elia served as CFO at Odeko, a privately held all-in-one operations partner for independent coffee shops, cafes and ot

      9/12/24 8:00:00 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • PetMed Express, Inc. Announces Appointment of Doug Krulik as Chief Accounting Officer

      DELRAY BEACH, Fla., Aug. 05, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) (the "Company") today announced the appointment of Doug Krulik as Chief Accounting Officer (CAO) effective August 19, 2024. Krulik comes to PetMeds with more than 20 years of leadership experience in finance and accounting, most recently with Etherio Holdings as its Vice President Finance and Controller. In this newly created role, he will oversee all aspects of the Company's accounting functions, including financial reporting, treasury, tax, compliance, and internal controls. Krulik will report directly to the Office of the Chief Financial Officer. "Doug'

      8/5/24 4:05:10 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • PetMed Express, Inc. Announces Strategic Updates to Executive Leadership Team

      Caroline Conegliano appointed Chief Operating Officer Umesh Sripad appointed Chief Digital and Technology Officer Company Announces CFO transition DELRAY BEACH, Fla., June 03, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) (the "Company") today announced several changes to its executive leadership team to further advance key initiatives to improve the customer experience, and to accelerate growth and profitability. Chief Operating Officer Caroline Conegliano joins PetMeds as Chief Operating Officer (COO), in a newly created role and expansion of the executive leadership team. Ms. Conegliano brings nearly two decades of experi

      6/3/24 8:00:00 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • PetMed Express, Inc. Appoints Carla Dodds as New Chief Marketing Officer

      DELRAY BEACH, Fla., May 28, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) (the "Company") today announced the appointment of Carla Dodds as Chief Marketing Officer (CMO). She brings extensive experience in leadership roles encompassing marketing, strategy and operations for major global companies including Walmart, MasterCard, Curacao, Omnilife-Chivas Group, and Penske Media Corporation. As CMO, Dodds will be responsible for leading PetMeds' integrated marketing strategy including brand and content, digital and lifecycle marketing, co-op media, customer acquisition and retention, customer insights and market research, social media

      5/28/24 8:00:00 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • PetMed Express, Inc. Announces Appointment of Justin Mennen to Board of Directors

      DELRAY BEACH, Fla., May 20, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., parent company of PetMeds and PetCareRx, (NASDAQ:PETS) (the "Company") today announced the appointment of Justin Mennen to the Company's Board of Directors ("the Board"), effective June 3, 2024. Mennen brings over 25 years of technology experience to the Company, including senior leadership roles at Rite Aid, CompuCom, Estée Lauder Companies and Dell Technologies. "Justin's vision and experience will be invaluable in advancing our digital initiatives and we are thrilled to have him join the Board," said Leslie C. G. Campbell, Chairman of the Board. "He has a strong track record of technology leadership ac

      5/20/24 8:00:00 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • PetMeds® Announces new Chairman of the Board

      DELRAY BEACH, Fla., Jan. 8, 2024 /PRNewswire/ -- PetMed Express, Inc. ("PetMeds®") (NASDAQ:PETS), Your Trusted Pet Health Expert™, announces the appointment of Leslie C. G. Campbell as Chairman of the Board effective January 5, 2024, as part of the company's ongoing Board composition and succession planning. Ms. Campbell has served on PetMeds' Board since 2018 and will continue to serve as Chair of the Compensation Committee and a member of the Audit and Corporate Governance and Nominating Committees. Ms. Campbell previously served as Chair of the Corporate Governance and Nomi

      1/8/24 5:46:00 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • PetMeds® Appoints Sandra Y. Campos to its Board of Directors

      DELRAY BEACH, Fla., May 18, 2023 (GLOBE NEWSWIRE) -- PetMed Express, Inc. ("PetMeds®") (NASDAQ:PETS), Your Trusted Pet Health Expert™, announced the appointment of Sandra Y. Campos to its Board of Directors effective May 17, 2023. "We are delighted to welcome Ms. Campos to PetMeds' board of directors," said Dr. Gian Fulgoni, Board Chairman. "Sandra's vast experience with brand management, digital transformations, and supply chain management, will undoubtedly help the Company as we continue to deliver "Nose-to-Tail" services to our pet families and continue to define the PetMeds' brand as "Your Trusted Pet Health Expert." Ms. Campos serves on the Boards of Big Lots, a nationwide retailer

      5/18/23 4:01:00 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • PetMeds® Hires Christine Chambers as Chief Financial Officer

      Seasoned executive brings a wealth of financial leadership to further accelerate the company's digital transformation. DELRAY BEACH, Fla., July 22, 2022 /PRNewswire-PRWeb/ -- PetMed Express, Inc. (NASDAQ:PETS), Your Trusted Pet Health Expert®, announces the appointment of Christine Chambers as its Chief Financial Officer, effective on August 3. Chambers is an experienced finance professional with extensive knowledge in the digital consumer space, most recently serving as Senior Vice President, CFO and Treasurer of Seattle-based RealNetworks. Prior to that, she was Vice President, Finance at Rosetta Stone. Chambers also has served as Deputy Director, Budget and Planning at the Bill & Melinda

      7/22/22 4:00:00 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    PetMed Express Inc. Press Releases

    Fastest customizable press release news feed in the world

    See more
    • PetMed Express, Inc. and Dutch Announce Partnership to Provide Accessible Telehealth Services for Pets

      DELRAY BEACH, Fla. and OAKLAND, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., parent company of PetMeds and PetCareRx (NASDAQ:PETS), today announced a new strategic partnership with virtual veterinary care provider Dutch. The collaboration marks PetMeds' latest move to expand its provider ecosystem with affordable, accessible pet healthcare options. The new partnership will enable pet parents to leverage Dutch's convenient technology and veterinary team to secure prescriptions for PetMeds' broad selection of medications in a timely manner. "This partnership expands the accessibility of pet telemedicine, which can help fill gaps in care, as the nationwide vet shortage has

      5/7/25 9:08:06 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • PetMeds® to Ring Nasdaq Opening Bell in Celebration of National Pet Day on April 11th

      DELRAY BEACH, Fla., April 11, 2025 (GLOBE NEWSWIRE) -- In celebration of National Pet Day, PetMed Express, Inc. (NASDAQ:PETS)—the original consumer pet healthcare company serving dogs, cats, and horses for nearly 30 years—will ring the Nasdaq Opening Bell this Friday, April 11, 2025. This momentous occasion honors the powerful bond between people and their pets and will feature adoptable rescue dogs from Bidawee, one of the nation's oldest no-kill animal welfare organizations. It's a tribute to the joy and unconditional love pets bring into our lives–and a reminder of how many still await families of their own. "Our pets are more than just animals; they are family," said Sandra Campo

      4/11/25 9:00:00 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • PetMed Express, Inc. Announces Appointment of Peter Batushansky to Board of Directors

      Former pet industry executive with more than 20 years of experience across retail, pet, healthcare, and private equity Third independent director to join the Board since 2024 Longtime board member and former Chairman Dr. Gian Fulgoni will retire DELRAY BEACH, Fla., April 09, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., parent company of PetMeds and PetCareRx, (NASDAQ:PETS) (the "Company") today announced the appointment of Peter Batushansky to the Company's Board of Directors ("the Board"), effective April 09, 2025. Mr. Batushansky is currently a Partner at L2 Capital Partners and brings to the Board more than 20 years of experience across retail, pet, healthcare and private equity, i

      4/9/25 8:00:00 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • PetMeds® Announces Third Quarter Fiscal 2025 Financial Results

      DELRAY BEACH, Fla., Feb. 10, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ:PETS) today announced its financial results for its third quarter ended December 31, 2024. Third Quarter Fiscal 2025 Financial Highlights Net sales of $53.0 million. Gross margin rate of 28.1%, an increase of 80 basis points compared to the prior year period. Adjusted EBITDA of $2.0 million compared to Adjusted EBITDA of $0.9 million in the prior year period. Continued progress on key initiatives supporting the transformation of the business. "In just nine months, we have made significant strides in our transformation journey, and I am pleased to report that

      2/10/25 4:05:00 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • PetMed Express, Inc. Sets Fiscal Third Quarter 2025 Earnings Call

      DELRAY BEACH, Fla., Jan. 30, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) will hold a conference call on Monday, February 10, 2025 at 4:30pm Eastern Time to discuss its financial results for the fiscal third quarter ended December 31, 2024. Financial results will be issued in a press release prior to the call. PETS management will host the conference call, followed by a question-and-answer period. Please call the conference telephone number 5-10 minutes prior to the start time. Date: Monday, February 10, 2025Time: 4:30pm Eastern Time (1:30pm Pacific Time)U.S. dial-in number: 877-407-0789International number: 201-689-8562Webcast

      1/30/25 4:05:00 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • PetMed Express, Inc. to Participate in the 27th Annual ICR Conference

      DELRAY BEACH, Fla., Jan. 07, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS), will participate in the 27th Annual ICR Conference, to be held January 13-15, 2025 in Orlando, FL. Sandra Campos, Chief Executive Officer and President, and Robyn D'Elia, Chief Financial Officer, will meet with investors and present at approximately 11:00 a.m. Eastern Time on Monday, January 13, 2025. A live webcast of the presentation will be available on the "Events & Presentations" section of PetMed's investor relations website at https://investors.petmeds.com. About PetMed Express, Inc. Founded in 1996, PetMeds is a leader in the consumer pet health

      1/7/25 8:00:00 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • PetMeds® Adopts Limited Duration Shareholder Rights Plan

      DELRAY BEACH, Fla., Dec. 03, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ:PETS) ("PetMeds" or the "Company"), today announced that its Board of Directors (the "Board") has adopted a limited duration shareholder rights plan to protect the best interests of all PetMeds shareholders (the "Rights Plan"). The Board adopted the Rights Plan to protect the investment of shareholders during a period in which it believes shares of the Company do not reflect the inherent value of the business or its long-term growth potential, and during which there have been recent significant accumulations of Company common stock by certain shareholders.

      12/3/24 8:30:00 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • PetMeds Migrates to Ordergroove as its New Subscription and Membership Technology Partner

      Ordergroove's technology streamlines the subscription and membership experience, with ready-to-use functionalities like prepaid subscriptions, self-service management, and personalized promotions. Ordergroove, the leading technology platform that powers subscriptions for top brands and retailers, today announced a strategic partnership with PetMed Express, Inc. (NASDAQ:PETS), the original online pet pharmacy dedicated to supporting the health and well-being of four-legged family members. This collaboration marks a significant step in modernizing and scaling PetMeds + PetCareRx's (PETS) subscription and membership capabilities to maximize operational efficiency and deliver innovative and e

      11/14/24 10:00:00 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • PetMed Express, Inc. to Participate in the Sidoti Micro Cap Conference

      DELRAY BEACH, Fla., Nov. 07, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS), will participate in the Sidoti Micro Cap Conference, to be held November 13-14, 2024 virtually. Sandra Campos, CEO and President, will meet with investors and present at approximately 1:45 p.m. Eastern Time on Wednesday, November 13, 2024. A live webcast of the presentation will be available on the "Events & Presentations" section of PetMed's investor relations website at https://investors.petmeds.com or directly here. About PetMed Express, Inc. Founded in 1996, PetMeds is a leader in the consumer pet healthcare sector. As a national online retailer wit

      11/7/24 4:05:00 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • PetMeds® Announces Second Quarter Fiscal 2025 Financial Results

      DELRAY BEACH, Fla., Nov. 06, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ:PETS) today announced its financial results for its second quarter ended September 30, 2024. Second Quarter Fiscal 2025 Financial Highlights Net sales of $59.6 million.Gross margin of 29.1%, an increase of 0.8% compared to the prior year period.Net income of $2.3 million, or $0.11 per diluted share, compared to net income of $0.7 million, or $0.03 per diluted share, in the prior year period.  Adjusted EBITDA of $2.1 million improved sequentially from an Adjusted EBITDA loss of $(1.5) million in the first quarter of fiscal 2025 and compared to Adjusted EBITDA of $

      11/6/24 4:05:00 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    PetMed Express Inc. SEC Filings

    See more
    • PetMed Express Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - PETMED EXPRESS INC (0001040130) (Filer)

      4/9/25 9:24:45 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • SEC Form 10-Q filed by PetMed Express Inc.

      10-Q - PETMED EXPRESS INC (0001040130) (Filer)

      2/10/25 5:14:56 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • PetMed Express Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - PETMED EXPRESS INC (0001040130) (Filer)

      2/10/25 5:12:32 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Amendment: SEC Form SCHEDULE 13G/A filed by PetMed Express Inc.

      SCHEDULE 13G/A - PETMED EXPRESS INC (0001040130) (Subject)

      1/31/25 9:56:44 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Amendment: PetMed Express Inc. filed SEC Form 8-K: Financial Statements and Exhibits

      8-K/A - PETMED EXPRESS INC (0001040130) (Filer)

      12/18/24 4:28:49 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • PetMed Express Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - PETMED EXPRESS INC (0001040130) (Filer)

      12/3/24 8:41:59 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • SEC Form 8-A12B filed by PetMed Express Inc.

      8-A12B - PETMED EXPRESS INC (0001040130) (Filer)

      12/3/24 8:39:44 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • SEC Form 10-Q filed by PetMed Express Inc.

      10-Q - PETMED EXPRESS INC (0001040130) (Filer)

      11/7/24 4:49:27 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • PetMed Express Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - PETMED EXPRESS INC (0001040130) (Filer)

      11/6/24 5:02:19 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • PetMed Express Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

      8-K - PETMED EXPRESS INC (0001040130) (Filer)

      9/27/24 4:10:44 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples